Journals / Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi / 2014 / Cilt: 24 - Sayı: 1

MUCOSITIS RELATED TO CHEMOTHERAPY

KEMOTERAPİYE BAĞLI MUKOZİT

Pages
158–161
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Risk assesment and effective preventive treatment is mandatory.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chemotherapy induced mucositis is a self-limited complication of systemic chemotherapy.
📊
Key Findings & Data:It is mainly due to the chemotherapy induced DNA damage of rapidly dividing epithelial cells and release and upregulation of reactive oxygene radicals.
💡
Conclusion & Impact:Risk assesment and effective preventive treatment is mandatory.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chemotherapy induced mucositis is a self-limited complication of systemic chemotherapy. It is mainly due to the chemotherapy induced DNA damage of rapidly dividing epithelial cells and release and upregulation of reactive oxygene radicals. In addition to interfering oral nutrition, mucositis can also leads to systemic bacteriemia fungemia and viremia due to the destruction of mucosal barrier against microbial agents. Although, several prophylactic and therapeutic approaches are available, most of them are ineffective. Risk assesment and effective preventive treatment is mandatory.

Özet

Kemoterapiye bağlı mukozit, sistemik kemoterapinin kişiye sınırlı bir kopmplikasyonudur. Esas olarak hızlı bölünen epitelyal hücrelerin kemoterapi tarafından uyarılan hasarı ve reaktif oksijen radikallerinin artması ve salınması sonucu gelişir. Oral beslenmeyi bozmasının yanı sıra mukozit aynı zamanda mikrobiyal ajanlara karşı mukozal bariyerin bozulması nedeniyle sistemik bakteriyemi, fungemi ve viremiye de yol açabilir. Her ne kadar çeşitli profilaktik ve terapötik yaklaşımlar mevcut olsa da bunlardan çoğu etkin değildir. Risk değerlendirmesi ve etkin önleyici tedavi gereklidir.

🔖

Cite This Article

KİKİ, İ. (2022). MUCOSITIS RELATED TO CHEMOTHERAPY. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi, Cilt: 24 - Sayı: 1, 158–161. https://ajindex.com/articles/452258

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Epstein JB, Thariat J, Bensadoun RJ, et al. Oral complications of cancer and cancer therapy: From cancer treatment to survivorship. CA Cancer J Clin 2012; 62:400-22.
  2. Krishna SG, Zhao W, Grazziutti ML, et al. Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients: clinical and research implications. Cancer 2011; 117:648-55.
  3. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer pathogenesis, measurement, epidemiology, and mucosal injury: RAD51 genes and clinical National Cancer Institute Common Toxicity Criteria. http://ctep.cancer.gov/protocolDevelopment/electr onic_applications/docs/ctcaev3.pdf (Accessed on March 08, 2011).
  4. Eisen D, Essell J, Broun ER. Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 1997 Dec;16:265-72.
  5. Ruescher TJ, Sodeifi A, Scrivani SJ, et al. The impact streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998; 82:2275- 81. on alpha-hemolytic DeGregorio MW, Lee WM, Ries CA. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982; 50: 2780-4.
  6. Elad S, Zadik Y, Hewson I, et al. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer. 2010;18:993- 1006. Whitley RJ, Gnann JW Jr. Acyclovir: a decade later. N Engl J Med 1992; 327:782-9.
  7. Djuric M, Hillier-Kolarov V, Belic A, et al. Mucositis prevention by improved dental care in acute leukemia patients. Support Care Cancer 2006; 14:137-46. Saadeh CE. Chemotherapy- and radiotherapy- induced oral mucositis: review of preventive strategies and treatment. Pharmacotherapy. 2005 Apr;25: 540-54.
  8. Mahood DJ, Dose AM, Loprinzi CL, et al. Inhibition of cryotherapy. J Clin Oncol 1991; 9: 449-52. stomatitis by oral Tartarone A, Matera R, Romano G, et al. Prevention of high-dose melphalan-induced mucositis by cryotherapy. Leuk Lymphoma 2005; 46:633-4.
  9. Farrell CL, Bready JV, Rex KL, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1998; 58: 933-9.
  10. Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109:820-31.
  11. Cowen D, Tardieu C, Schubert M, et a